About Eukaryotic initiation factor 4A-II
Eukaryotic initiation factor 4A-II (EIF4A2) is a protein
from Homo sapiens identified by UniProt accession
Q14240, 407 residues long.
MolForge cross-references it against 0 known binders and
150 disease associations.
Target properties
| Protein name | Eukaryotic initiation factor 4A-II |
| UniProt accession | Q14240 |
| Gene | EIF4A2 |
| Organism | Homo sapiens |
| Length | 407 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (150)
Diseases linked to this target (Open Targets).
- neurodevelopmental disorder with hypotonia and speech delay, with or without seizures · score 0.60
- Neurodevelopmental disorder · score 0.56
- complex neurodevelopmental disorder · score 0.37
- neurodegenerative disease · score 0.36
- Neurodevelopmental delay · score 0.26
- acute myeloid leukemia · score 0.20
- esophageal squamous cell carcinoma · score 0.20
- hepatocellular carcinoma · score 0.20
- diffuse large B-cell lymphoma · score 0.20
- non-small cell lung carcinoma · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q14240-F1 | alphafold | PREDICTED | 86.36 | — |
Amino-acid sequence (407 residues)
MSGGSADYNR EHGGPEGMDP DGVIESNWNE IVDNFDDMNL KESLLRGIYA YGFEKPSAIQ QRAIIPCIKG YDVIAQAQSG TGKTATFAIS ILQQLEIEFK ETQALVLAPT RELAQQIQKV ILALGDYMGA TCHACIGGTN VRNEMQKLQA EAPHIVVGTP GRVFDMLNRR YLSPKWIKMF VLDEADEMLS RGFKDQIYEI FQKLNTSIQV VLLSATMPTD VLEVTKKFMR DPIRILVKKE ELTLEGIKQF YINVEREEWK LDTLCDLYET LTITQAVIFL NTRRKVDWLT EKMHARDFTV SALHGDMDQK ERDVIMREFR SGSSRVLITT DLLARGIDVQ QVSLVINYDL PTNRENYIHR IGRGGRFGRK GVAINFVTEE DKRILRDIET FYNTTVEEMP MNVADLI
Explore Eukaryotic initiation factor 4A-II with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets